Search Within

Department of Medicine

Formats
  1. Journal Article (19618)
  2. Meeting Abstract (16046)
  3. Review (1158)
  4. Book Section (934)
  5. Editorial (611)
  6. Research Letter (316)
  7. Conference Paper (301)
  8. Guidelines (298)
  9. Correspondence (236)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22348)
  2. Hematologic Malignancies, Division of (13287)
  3. Center for Hematologic Malignancies (11069)
  4. GSK Faculty (10653)
  5. Survivorship Research (9346)
  6. Division of Subspecialty Medicine (7554)

More Groups

People
  1. Robert Motzer (1249)
  2. Howard Scher (1133)
  3. Sergio Giralt (1069)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (906)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1118)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6458)
  2. Elsevier Inc. (4216)
  3. American Society of Hematology (4003)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2291)
  6. Nature Publishing Group (2121)

More Publishers

Results (39669)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase I/II trial of gefitinib and RAD001 (everolimus) in patients (pts) with advanced non-small cell lung cancer (NSCLC)
    Meeting Abstract

    Milton, D. T.; Kris, M. G.; Azzoli, C. G.; Gomez, J. E.; Heelan, R.; Krug, L. M.; Pao, W.; Pizzo, B.; Rizvi, N. A.; Miller, V. A.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Phase 1/2 dose escalation trial of the prostate-specific membrane antigen (PSMA)targeted immunoconjugate MLN2704 in patients with progressive metastatic castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Milowsky, M. I.; Galsky, M.; Lewin, J.; Rozario, C. P.; Owens, L.; Marshall, T.; Nanus, D.; Webb, I. J.; Scher, H. I.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • EGFR mutation, immumohistochemistry (IHC) and chromogenic in situ hybridization (CISH) as predictors of sensitivity to erlotinib and gefitinib in patients (pts) with NSCLC
    Meeting Abstract

    Miller, V. A.; Zakowski, M.; Riely, G. J.; Pao, W.; Hussain, S.; Ladanyi, M.; Heelan, R. T.; Kris, M. G.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • The impact of physical activity on patients with stage III colon cancer: Findings from Intergroup trial CALGB 89803
    Meeting Abstract

    Meyerhardt, J. A.; Heseltine, D.; Niedzwiecki, D.; Hollis, D.; Saltz, L. B.; Mayer, R. J.; Schilsky, R. L.; Fuchs, C. S.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Generation of specific human CD8+T cell responses to the myeloproliferative disorder associated V617F mutated JAK2 kinase by use of analog peptide vaccine candidates
    Meeting Abstract

    May, R. J.; Korontsvit, T.; Zakhaleva, V.; Gomez, M.; Dao, T.; Scheinberg, D. A.
    Blood (2005)

    Fulltext@MSK | Save
  • Prevalence of BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish (AJ) families with breast cancer (BC) and pancreatic cancer (PC)
    Meeting Abstract

    Marcotrigiano, M. C.; Wadsworth, E.; Balistreri, L.; Schluger, A.; Offit, K.; Robson, M.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Conditional inactivation of the proto-oncogene Pokemon results in block of differentiation in multiple hematopoietic lineages
    Meeting Abstract

    Maeda, T.; Merghoub, T.; Hobbs, R.; Dong, L.; Maeda, M.; Zelent, A.; Teruya-Feldstein, J.; Pandolfi, P. P.
    Blood (2005)

    Fulltext@MSK | Save
  • The fate of low affinity tumor-specific CD8+T cells in tumor bearing mice
    Meeting Abstract

    Lyman, M. A.; Nugent, C. T.; Marquardt, K. L.; Biggs, J. A.; Pamer, E. G.; Sherman, L. A.
    FASEB Journal (2005)

    Fulltext@MSK | Save
  • Correlation of molecular markers including mutations with clinical outcomes in advanced non small cell lung cancer (NSCLC) patients (pts) treated with gefitinib, chemotherapy or chemotherapy and gefitinib in IDEAL and INTACT clinical trials
    Meeting Abstract

    Lynch, T. J.; Bell, D.; Haber, D.; Johnson, D.; Giaccone, G.; Fukuoka, M.; Kris, M.; Herbst, R.; Krebs, A.; Ochs, J.
    Journal of Clinical Oncology (2005)

    Fulltext@MSK | Save
  • Clinics and epidemiology of hereditary breast cancer
    Meeting Abstract

    Lubinski, J.; GoĢrski, B.; Cybulski, C.; Huzarski, T.; Byrski, T.; Gronwald, J.; Jakubowska, A.; Stawicka, M.; Gozdecka-Grodecka, S.; Szwiec, M.; more...
    Toxicology Letters (2005)

    Fulltext@MSK | Save